Page 2 - Hong Kong (HSI) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2552 Hua Medicine (Shanghai)	HK$1.53	0%	-36.5%	HK$1.5b	n/a	PS18.1x	n/a	n/a
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$175.70	0%	n/a	HK$38.5b	HK$184.04	PS23.1x	E29.0%	n/a
6855 Ascentage Pharma Group International	HK$21.00	0%	5.8%	HK$6.0b	HK$29.48	PS24.9x	E17.7%	n/a
2181 Mabpharm	HK$0.38	0%	-36.4%	HK$1.5b	n/a	PS16.4x	n/a	n/a
2480 Beijing Luzhu Biotechnology	HK$25.40	0%	3.0%	HK$5.1b	HK$29.98	PB4.7x	E36.3%	n/a
1875 TOT BIOPHARM International	HK$2.00	0%	-21.6%	HK$1.5b	HK$3.80	PS1.8x	n/a	n/a
950 Lee's Pharmaceutical Holdings	HK$1.16	0%	-24.2%	HK$683.0m	HK$1.00	PE40.9x	S16.1%	1.6%
1652 Fusen Pharmaceutical	HK$1.00	0%	-27.0%	HK$739.3m	n/a	PS1.2x	n/a	0%
2509 Qyuns Therapeutics	HK$29.20	0%	n/a	HK$6.5b	n/a	PS406.6x	n/a	n/a
2142 HBM Holdings	HK$1.44	0%	-21.7%	HK$1.1b	n/a	PE5.9x	n/a	n/a
9969 InnoCare Pharma	HK$5.13	0%	-39.4%	HK$10.1b	HK$9.77	PS11.7x	E21.3%	n/a
690 Uni-Bio Science Group	HK$0.077	0%	40.0%	HK$474.6m	n/a	PE6.7x	n/a	n/a
9966 Alphamab Oncology	HK$5.22	0%	-60.5%	HK$4.9b	HK$3.93	PS20.7x	E1.6%	n/a
6185 CanSino Biologics	HK$21.15	0%	-36.8%	HK$9.3b	HK$27.77	PS13x	E124.6%	0%
6826 Shanghai Haohai Biological Technology	HK$42.30	0%	-2.0%	HK$15.1b	HK$70.01	PE15.1x	n/a	2.6%
2877 China Shineway Pharmaceutical Group	HK$9.89	0%	6.0%	HK$7.5b	HK$14.10	PE7.1x	E14.5%	5.8%
8329 Shenzhen Neptunus Interlong Bio-technique	HK$0.14	0%	-2.0%	HK$243.3m	n/a	PE9.3x	n/a	n/a
8247 Biosino Bio-Technology and Science Incorporation	HK$0.90	0%	-16.7%	HK$130.2m	n/a	PB0.6x	n/a	0%
2616 CStone Pharmaceuticals	HK$1.10	0%	-64.2%	HK$1.4b	HK$3.45	PS2.8x	E56.9%	n/a
8225 China Health Group	HK$0.12	0%	-42.9%	HK$119.4m	n/a	PS5.2x	n/a	n/a
2105 Laekna	HK$7.80	0%	n/a	HK$3.0b	n/a	PS5987.7x	n/a	n/a
2511 HighTide Therapeutics	HK$6.95	0%	n/a	HK$3.6b	HK$17.00	PB4.7x	n/a	n/a
1548 Genscript Biotech	HK$12.42	0%	-39.0%	HK$26.4b	HK$28.86	PS4x	E88.4%	0%
2162 Keymed Biosciences	HK$39.40	0%	-33.6%	HK$10.9b	HK$57.96	PS28.5x	E-9.1%	n/a